BRANCH OFFICES
Our branch offices are designed to meet diverse needs, with a welcoming atmosphere and a dedicated team ready to assist you. Equipped with cutting-edge technology, we aim to provide efficient, convenient, and innovative solutions.
Germany
Bremen - HQ
While our clinical trials are conducted across Europe and globally, our main office in Bremen, Germany serves as the central hub for to coordinate all of our services. From here, we guide our clients in every aspect of clinical trials, ensuring consistency, compliance, and efficiency across all study locations.
Bremen’s strategic location in northern Germany offers excellent connectivity within Europe, making it an ideal base for international operations. Our team in Bremen provides end-to-end support, from regulatory strategy and ethics submissions to project management and oversight — giving sponsors a single, reliable point of contact throughout the clinical trial journey.
Do you need help running your clinical trial? Reach out to us via germany@gcp-service.com
Dr. Andreas Beust
CEO of GCPS
Bremen - HQ
While our clinical trials are conducted across Europe and globally, our main office in Bremen, Germany serves as the central hub for to coordinate all of our services. From here, we guide our clients in every aspect of clinical trials, ensuring consistency, compliance, and efficiency across all study locations.
Bremen’s strategic location in northern Germany offers excellent connectivity within Europe, making it an ideal base for international operations. Our team in Bremen provides end-to-end support, from regulatory strategy and ethics submissions to project management and oversight — giving sponsors a single, reliable point of contact throughout the clinical trial journey.
Do you need help running your clinical trial? Reach out to us via germany@gcp-service.com
Dr. Andreas Beust
CEO of GCPS
Siegburg
Located in North Rhine-Westphalia, our office in Siegburg is located strategically near research hubs such as Cologne, Bonn, Düsseldorf or Aachen. Our office in Siegburg specializes in Sponsorship-as-a-Service, providing medical device manufacturers and initiators of investigator-initiated trials with comprehensive support to navigate the German, European or international regulatory landscape efficiently.
With a strong healthcare system and proximity to research hubs, Siegburg offers access to hospitals, clinics, and a highly educated patient population. The network of universities, research centers, and specialized hospitals ensures trials are supported by expertise and modern infrastructure.
Concentrated research sites, experienced staff, and connections with key opinion leaders accelerate study start-up and patient recruitment. Our office in Siegburg is a key part of our full-service support, from regulatory guidance to operational oversight, making trials faster, cost-effective, and reliable.
Want to learn more about Sponsorship as a Service? Reach out to us via germany@gcp-service.com
Katharina Mohr
Regional Operations Manager
Siegburg
Located in North Rhine-Westphalia, our office in Siegburg is located strategically near research hubs such as Cologne, Bonn, Düsseldorf or Aachen. Our office in Siegburg specializes in Sponsorship-as-a-Service, providing medical device manufacturers and initiators of investigator-initiated trials with comprehensive support to navigate the German, European or international regulatory landscape efficiently.
With a strong healthcare system and proximity to research hubs, Siegburg offers access to hospitals, clinics, and a highly educated patient population. The network of universities, research centers, and specialized hospitals ensures trials are supported by expertise and modern infrastructure.
Concentrated research sites, experienced staff, and connections with key opinion leaders accelerate study start-up and patient recruitment. Our office in Siegburg is a key part of our full-service support, from regulatory guidance to operational oversight, making trials faster, cost-effective, and reliable.
Want to learn more about Sponsorship as a Service? Reach out to us via germany@gcp-service.com
Katharina Mohr
Regional Operations Manager
Poland
Gdynia
Poland has become one of Europe’s leading destinations for clinical research. In 2021, the Polish Medical Research Agency reported more than 800 active clinical trials, and today international registries show well over 1,500 studies ongoing. Globally, Poland has consistently ranked among the top countries for innovative biopharmaceutical trials, reaching the 11th position worldwide in 2019 and maintaining a strong presence since.
Clinical trials in Poland cover all phases, with Phase III studies making up the largest share, followed by Phase II and a smaller but growing proportion of Phase I. The country’s population of more than 38 million offers a large and diverse participant pool, supported by rising public awareness and government-backed recruitment initiatives.
With over two decades of experience, Poland boasts a well-established infrastructure, highly trained investigators, and competitive costs, giving sponsors an excellent price-to-quality ratio. The ongoing expansion of the Polish Clinical Trials Network and significant public investment further strengthen Poland’s position as a trusted, cost-effective hub for high-quality clinical research.
Consider Poland for your trial. Contact us at poland@gcp-service.com
Joanna Wilinska
Regional Operations Manager
Gdynia
Poland has become one of Europe’s leading destinations for clinical research. In 2021, the Polish Medical Research Agency reported more than 800 active clinical trials, and today international registries show well over 1,500 studies ongoing. Globally, Poland has consistently ranked among the top countries for innovative biopharmaceutical trials, reaching the 11th position worldwide in 2019 and maintaining a strong presence since.
Clinical trials in Poland cover all phases, with Phase III studies making up the largest share, followed by Phase II and a smaller but growing proportion of Phase I. The country’s population of more than 38 million offers a large and diverse participant pool, supported by rising public awareness and government-backed recruitment initiatives.
With over two decades of experience, Poland boasts a well-established infrastructure, highly trained investigators, and competitive costs, giving sponsors an excellent price-to-quality ratio. The ongoing expansion of the Polish Clinical Trials Network and significant public investment further strengthen Poland’s position as a trusted, cost-effective hub for high-quality clinical research.
Consider Poland for your trial, contact us at poland@gcp-service.com
Joanna Wilinska
Regional Operations Manager
Netherlands
Nijmegen
The Netherlands is a leading hub for clinical research in Europe, combining advanced infrastructure, a highly educated workforce, and an efficient regulatory environment. With a population of about 17.5 million and a dense network of hospitals and eight top University Medical Centers, the country offers streamlined patient recruitment and high-quality trial execution.
Each year, roughly 600 new clinical trials are initiated, involving nearly 60,000 participants, supported by more than 65,000 life sciences and health professionals, including around 7,800 dedicated clinical researchers. Strong regulatory bodies, such as the Dutch Medicines Evaluation Board (CBG) and the Central Committee on Research Involving Human Subjects (CCMO), ensure fast, reliable approvals, while the Netherlands’ central location in Europe makes it ideal for multinational studies. These factors together establish the Netherlands as a trusted, efficient, and innovative destination for clinical trials.
If you are interested in exploring how Dutch clinical research excellence can benefit your trial, contact us at netherlands@gcp-service.com
René Pules
Managing Director
Nijmegen
The Netherlands is a leading hub for clinical research in Europe, combining advanced infrastructure, a highly educated workforce, and an efficient regulatory environment. With a population of about 17.5 million and a dense network of hospitals and eight top University Medical Centers, the country offers streamlined patient recruitment and high-quality trial execution.
Each year, roughly 600 new clinical trials are initiated, involving nearly 60,000 participants, supported by more than 65,000 life sciences and health professionals, including around 7,800 dedicated clinical researchers. Strong regulatory bodies, such as the Dutch Medicines Evaluation Board (CBG) and the Central Committee on Research Involving Human Subjects (CCMO), ensure fast, reliable approvals, while the Netherlands’ central location in Europe makes it ideal for multinational studies. These factors together establish the Netherlands as a trusted, efficient, and innovative destination for clinical trials.
If you are interested in exploring how Dutch clinical research excellence can benefit your trial, contact us at netherlands@gcp-service.com
René Pules
Managing Director
Czech Republic
Prague
The Czech Republic has emerged as a prominent destination for clinical trials in Central Europe, offering a robust healthcare infrastructure, a skilled workforce, and a supportive regulatory environment. As of 2025, the country hosts over 1,000 active clinical trials, including a 40% increase in cancer drug studies in 2023. With a population exceeding 10.5 million, the Czech Republic provides a well-organized system for efficient patient recruitment and high-quality research. The State Institute for Drug Control (SÚKL) ensures compliance with EU regulations, maintaining high standards of safety and efficacy.
The Czech Clinical Research Infrastructure Network (CZECRIN) supports academic clinical trials, connecting major clinical sites and providing knowledge, development, and implementation capacities for drug and medical device research. The country has demonstrated particular strength in neurology and oncology research, with a significant number of trials in these areas. Combined with competitive costs and adherence to the EU Clinical Trials Regulation (EU CTR), these factors make the Czech Republic an attractive destination for high-quality clinical trials.
Do you need help running your clinical trial? Reach out to us via CEE@gcp-service.com
Tomáš Scheiner
Regional Operations Manager
Prague
The Czech Republic has emerged as a prominent destination for clinical trials in Central Europe, offering a robust healthcare infrastructure, a skilled workforce, and a supportive regulatory environment. As of 2025, the country hosts over 1,000 active clinical trials, including a 40% increase in cancer drug studies in 2023. With a population exceeding 10.5 million, the Czech Republic provides a well-organized system for efficient patient recruitment and high-quality research. The State Institute for Drug Control (SÚKL) ensures compliance with EU regulations, maintaining high standards of safety and efficacy.
The Czech Clinical Research Infrastructure Network (CZECRIN) supports academic clinical trials, connecting major clinical sites and providing knowledge, development, and implementation capacities for drug and medical device research. The country has demonstrated particular strength in neurology and oncology research, with a significant number of trials in these areas. Combined with competitive costs and adherence to the EU Clinical Trials Regulation (EU CTR), these factors make the Czech Republic an attractive destination for high-quality clinical trials.
Do you need help running your clinical trial? Reach out to us via CEE@gcp-service.com
Tomáš Scheiner
Regional Operations Manager
Slovakia
Bratislava
Slovakia offers a well-educated population, a robust healthcare infrastructure, and a growing track record in clinical research. With a population of around 5.5 million, 12 university hospitals, and a network of experienced investigators, the country ensures efficient trial execution and high-quality data (gctrials.com). Slovakia joined the European Clinical Research Infrastructure Network (ECRIN) in 2025, reflecting its adherence to European standards and facilitating multinational trials. The regulatory environment aligns with EU Clinical Trials Regulation (EU-CTR), streamlining approvals and reducing administrative burden. With strengths in oncology and cardiology, motivated investigators, efficient patient recruitment, and competitive costs, Slovakia is an attractive destination for high-quality clinical trials.
If you would like to benefit from great patient recruitment and retention for your trials, reach out to us at slovakia@gcp-service.com.
Tomáš Scheiner
Regional Operations Manager
Bratislava
Slovakia offers a well-educated population, a robust healthcare infrastructure, and a growing track record in clinical research. With a population of around 5.5 million, 12 university hospitals, and a network of experienced investigators, the country ensures efficient trial execution and high-quality data (gctrials.com). Slovakia joined the European Clinical Research Infrastructure Network (ECRIN) in 2025, reflecting its adherence to European standards and facilitating multinational trials. The regulatory environment aligns with EU Clinical Trials Regulation (EU-CTR), streamlining approvals and reducing administrative burden. With strengths in oncology and cardiology, motivated investigators, efficient patient recruitment, and competitive costs, Slovakia is an attractive destination for high-quality clinical trials.
If you would like to benefit from great patient recruitment and retention for your trials, reach out to us at slovakia@gcp-service.com.
Tomáš Scheiner
Regional Operations Manager
Ireland
Ireland has become a key location for clinical trials, supported by a strong life sciences sector and advanced healthcare system. With 70,000+ professionals working in pharmaceuticals, biotech, and medical research, Ireland provides sponsors with access to a highly skilled workforce.
The country’s network of hospitals, universities, and research centers ensures expertise across therapeutic areas. Combined with government investment and a business-friendly environment, Ireland offers a streamlined and cost-effective setting for clinical studies.
Ready to leverage Ireland’s expertise for your clinical trials? Contact us today at info@gcp-service.com.
Ireland has become a key location for clinical trials, supported by a strong life sciences sector and advanced healthcare system. With 70,000+ professionals working in pharmaceuticals, biotech, and medical research, Ireland provides sponsors with access to a highly skilled workforce.
The country’s network of hospitals, universities, and research centers ensures expertise across therapeutic areas. Combined with government investment and a business-friendly environment, Ireland offers a streamlined and cost-effective setting for clinical studies.
Ready to leverage Ireland’s expertise for your clinical trials? Contact us today at info@gcp-service.com.
United Kingdom
The UK is one of the most established locations for clinical trials worldwide. With over 1,200 hospitals and 140 universities, it offers extensive infrastructure and expertise across all trial phases. The country’s large and diverse patient population enables efficient recruitment and representative study outcomes.
The UK is home to world-class research centers and the NHS clinical trial networks, which support rapid study start-up and high-quality execution. Its experienced investigators and robust regulatory framework ensure compliance and innovation at every stage.
Tap into the UK’s world-class clinical trial capabilities. Contact us at info@gcp-service.com.
The UK is one of the most established locations for clinical trials worldwide. With over 1,200 hospitals and 140 universities, it offers extensive infrastructure and expertise across all trial phases. The country’s large and diverse patient population enables efficient recruitment and representative study outcomes.
The UK is home to world-class research centers and the NHS clinical trial networks, which support rapid study start-up and high-quality execution. Its experienced investigators and robust regulatory framework ensure compliance and innovation at every stage.
Tap into the UK’s world-class clinical trial capabilities. Contact us at info@gcp-service.com.
France
Paris
France is one of Europe’s strongest hubs for clinical trials, combining a world-class healthcare system, highly skilled professionals, and advanced research infrastructure. With a population of over 67 million, France offers a large and diverse patient pool, ensuring efficient recruitment and robust study outcomes.
The country is home to more than 1,400 hospitals and 70+ universities, many with specialized research centers and clinical departments. France also boasts a thriving pharmaceutical and biotech industry, supported by over 100,000 life sciences professionals and strong government investment in research.
Its robust regulatory framework, experienced investigators, and well-established trial networks make France a reliable choice for sponsors seeking quality and efficiency.
Harness France’s expertise in clinical trials. Contact us at info@gcp-service.com.
Amandine Guilmandie, MSc
Regional Operations Manager
Paris
France is one of Europe’s strongest hubs for clinical trials, combining a world-class healthcare system, highly skilled professionals, and advanced research infrastructure. With a population of over 67 million, France offers a large and diverse patient pool, ensuring efficient recruitment and robust study outcomes.
The country is home to more than 1,400 hospitals and 70+ universities, many with specialized research centers and clinical departments. France also boasts a thriving pharmaceutical and biotech industry, supported by over 100,000 life sciences professionals and strong government investment in research.
Its robust regulatory framework, experienced investigators, and well-established trial networks make France a reliable choice for sponsors seeking quality and efficiency.
Harness France’s expertise in clinical trials. Contact us at info@gcp-service.com.
Amandine Guilmandie, MSc
Regional Operations Manager
Singapore
Singapore has established itself as a powerhouse for clinical research, thanks to its world-class healthcare system, skilled workforce, and advanced research infrastructure. Its diverse, multicultural population makes it an excellent setting to coordinate clinical research throughout south-east Asia and beyond.
Home to over 30 hospitals and specialty centers, Singapore also hosts major pharmaceutical and biotech companies, supported by strong government investment in research and innovation. Its robust regulatory framework ensures compliance and quality, and regulatory alliances such as the Access Consortium and ACTD/ACTR help align regulatory expectations.
With experienced investigators, cutting-edge facilities, and strategic connectivity across Asia and Australia, Singapore offers sponsors a streamlined environment to conduct or coordinate clinical studies.
Accelerate your clinical trials in Singapore. Reach out to info@gcp-service.com.
Dr. Andreas Beust
Regional Operations Manager
Singapore
Singapore has established itself as a powerhouse for clinical research, thanks to its world-class healthcare system, skilled workforce, and advanced research infrastructure. Its diverse, multicultural population makes it an excellent setting to coordinate clinical research throughout south-east Asia and beyond.
Home to over 30 hospitals and specialty centers, Singapore also hosts major pharmaceutical and biotech companies, supported by strong government investment in research and innovation. Its robust regulatory framework ensures compliance and quality, and regulatory alliances such as the Access Consortium and ACTD/ACTR help align regulatory expectations.
With experienced investigators, cutting-edge facilities, and strategic connectivity across Asia and Australia, Singapore offers sponsors a streamlined environment to conduct or coordinate clinical studies.
Accelerate your clinical trials in Singapore. Reach out to info@gcp-service.com.
Dr. Andreas Beust